Skip to content
healthcare.dev

ZELVYSIA

NDC 73289-0071, sapropterin dihydrochloride, powder, for solution, from Aucta Pharmaceuticals, Inc..

Product NDC
73289-0071
Status
Listed
Labeler
Aucta Pharmaceuticals, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218645
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0071 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SAPROPTERIN DIHYDROCHLORIDE500 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Phenylalanine Hydroxylase Activator [EPC]; Phenylalanine Hydroxylase Activators [MoA]

Package NDCNDC-11Package
73289-0071-27328900710230 PACKET in 1 CARTON (73289-0071-2) / 1 POWDER, FOR SOLUTION in 1 PACKET (73289-0071-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8de84882-dd24-46f2-8416-5e492d4275d1

Use it

Look up 73289-0071 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73289-0071 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73289-0071. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.